A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
一项双盲随机安慰剂对照 I/II 期研究，评估同种异体骨髓间充质干细胞治疗严重肢体缺血的安全性和有效性
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/1479-5876-11-143
Gupta Pawan K, Chullikana Anoop, Parakh Rajiv, Desai Sanjay, Das Anjan, Gottipamula Sanjay, Krishnamurthy Sagar, Anthony Naveen, Pherwani Arun, Majumdar Anish S
